Biopsy Data Articles & Analysis

1 articles found

Nanostics Announces Study Data Supporting ClarityDX Prostate as a Reflex Test to Predict Clinically Significant Prostate Cancer

PSA test alone could have resulted in 37% fewer unnecessary biopsies. The clinical study recruited men from two sites in Alberta, Canada, and one site in Baltimore, USA. EDMONTON, AB, June 30, 2022 /CNW/ - Nanostics Inc., a precision health diagnostics company, today announces positive data from a pre-biopsy clinical validation study of its ...

Jul. 30, 2022

ByNanostics Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you